FDA to Convene Pharmacy Compounding Advisory Committee in July When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions FDA Puts BPC 157, TB 500, and 5 Other Peptides Under the Microscope: What Prescribers Need to Know About the 503A Review Lengea FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of FDA considers adding a dozen peptides to its bulk drug compounding list RAPS Excellent news for us on the frontiers of medicine. Bringing back peptides to compounding pharmacies is the long awaited expectation from this administration. I voted for this. In September 2023, the Biden